FDA Probes Testosterone Products For Fatal Risks

Law360, New York (January 31, 2014, 7:04 PM EST) -- The U.S. Food and Drug Administration on Friday said it is investigating possible increased risks of stroke, heart attack and death in men using testosterone replacement therapies, a move that imperils a booming pharmaceutical field and follows recent studies that raised red flags.

While cautioning that it has not reached any conclusions about possible dangers, the FDA said it launched an inquiry after the recent publication of two research articles that found elevated cardiovascular risks in men using testosterone replacement products.

One study, published in November...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.